Crossmark

Comparative efficacy and safety of tumor necrosis factor inhibitors and their biosimilars in patients with rheumatoid arthritis having an insufficient response to methotrexate

Crossref DOI link: https://doi.org/10.1007/s00393-021-01041-z

Published Online: 2021-07-05

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ho Lee, Young https://orcid.org/0000-0003-4213-1909
Gyu Song, Gwan
License Information

Text and Data Mining valid from 2021-07-05

Version of Record valid from 2021-07-05
More Information

Article History

Accepted: 6 June 2021

First Online: 5 July 2021

Declarations

:

: Y. Ho Lee and G. Gyu Song declare that they have no competing interests.

: For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.

Document is current

Any future updates will be listed below